Comparative evaluation of the efficacy and safety of crisaborole ointment (2%) versus tacrolimus ointment (0.1%) for the topical treatment of atopic dermatitis: an open‐labeled single‐blinded randomized controlled trial

Documenti analoghi

• Real‐world efficacy of 2% crisaborole ointment on chronic hyperplasia lesions in 49 patients with atopic dermatitis
  di: Chuan Ma, et al.
  Pubblicazione: (2024)
• Dupilumab facial dermatitis in atopic dermatitis patients ameliorated by topical crisaborole: An open‐label case series study
  di: Han‐Wen Lin, et al.
  Pubblicazione: (2024)
• Disseminated superficial porokeratosis: two case reports of successful treatment with 2% crisaborole ointment
  di: Yimin Liang, et al.
  Pubblicazione: (2024)
• A case of Conradi‐Hünermann‐Happle syndrome treated with topical simvastatin‐cholesterol ointment
  di: Jean Zevallos, et al.
  Pubblicazione: (2024)
• Simulium dermatitis following blackfly bites in Northeastern India: a case report
  di: Koushik Lahiri, et al.
  Pubblicazione: (2024)